BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8435322)

  • 1. Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia.
    Zauli G; Visani G; Catani L; Vianelli N; Gugliotta L; Capitani S
    Br J Haematol; 1993 Jan; 83(1):14-20. PubMed ID: 8435322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
    Martyré MC; Magdelenat H; Bryckaert MC; Laine-Bidron C; Calvo F
    Br J Haematol; 1991 Jan; 77(1):80-6. PubMed ID: 1998600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential thrombocythemia: impaired regulation of megakaryocyte progenitors.
    Zauli G; Catani L; Gugliotta L; Gaggioli L; Vitale L; Belmonte MM; Aglietta M; Bagnara GP
    Int J Cell Cloning; 1991 Jan; 9(1):43-56. PubMed ID: 2010654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive effects of TNF-alpha, TGF-beta1, and chemokines on megakaryocytic colony formation in CD34+ cells derived from umbilical cord blood compared with mobilized peripheral blood and bone marrow.
    Lu L; Wang LS; Cooper RJ; Liu HJ; Turner K; Weich N; Broxmeyer HE
    J Hematother Stem Cell Res; 2000 Apr; 9(2):195-204. PubMed ID: 10813532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
    Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum levels of transforming growth factor beta-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis.
    Zauli G; Gugliotta L; Catani L; Vianelli N; Borgatti P; Belmonte MM; Tura S
    Br J Haematol; 1993 Jul; 84(3):381-6. PubMed ID: 8217789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of the primitive megakaryocyte progenitors (BFU-meg) in adult human peripheral blood.
    Zauli G; Vitale L; Brunelli MA; Bagnara GP
    Exp Hematol; 1992 Aug; 20(7):850-4. PubMed ID: 1378407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-11 (IL-11) and IL-9 counteract the inhibitory activity of transforming growth factor beta 3 (TGF-beta 3) on human primitive hematopoietic progenitor cells.
    Lemoli RM; Fogli M; Fortuna A; Tura S
    Haematologica; 1995; 80(1):5-12. PubMed ID: 7758992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megakaryocytic colony formation (CFU-Meg) in essential thrombocythemia: quantitative and qualitative abnormalities of bone marrow CFU-Meg.
    Kimura H; Ishibashi T; Sato T; Matsuda S; Uchida T; Kariyone S
    Am J Hematol; 1987 Jan; 24(1):23-30. PubMed ID: 3799592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
    Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
    Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 and beta thromboglobulin: comparative analysis in bone marrow cultures from normal individuals and patients with essential thrombocythaemia and immune thrombocytopenic purpura.
    Han ZC; Bellucci S; Tenza D; Caen JP
    Br J Haematol; 1990 Apr; 74(4):395-401. PubMed ID: 2140694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary polycythaemia, essential thrombocythaemia and myelofibrosis--three facets of a single disease process?
    Adams JA; Barrett AJ; Beard J; McCarthy DM
    Acta Haematol; 1988; 79(1):33-7. PubMed ID: 3124458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
    Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
    Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia.
    Carlo-Stella C; Cazzola M; Gasner A; Barosi G; Dezza L; Meloni F; Pedrazzoli P; Hoelzer D; Ascari E
    Blood; 1987 Oct; 70(4):1014-9. PubMed ID: 3115331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3.
    Kobayashi S; Teramura M; Hoshino S; Motoji T; Oshimi K; Mizoguchi H
    Br J Haematol; 1993 Apr; 83(4):539-44. PubMed ID: 7686030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trauma inhibits erythroid burst-forming unit and granulocyte-monocyte colony-forming unit growth through the production of TGF-beta1 by bone marrow stroma.
    Wu JC; Livingston DH; Hauser CJ; Deitch EA; Rameshwar P
    Ann Surg; 2001 Aug; 234(2):224-32. PubMed ID: 11505069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type beta transforming growth factor (TGF-beta).
    Mitjavila MT; Vinci G; Villeval JL; Kieffer N; Henri A; Testa U; Breton-Gorius J; Vainchenker W
    J Cell Physiol; 1988 Jan; 134(1):93-100. PubMed ID: 3422078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.